Last Updated: Tuesday, April 28, 2015, 10:37
Pharmaceuticals major Wockhardt is recalling 13 drugs in the US, manufactured at its two units at Chikalthana and Waluj in Maharashtra, which were under import restrictions from the USFDA.
Last Updated: Wednesday, March 18, 2015, 19:03
"The recent inspection at the Aurangabad L1-Chikalthana site was a follow-up inspection by the US FDA as an outcome of completion of good manufacturing practise (GMP) remediation submitted by Wockhardt in October 2014.
Last Updated: Thursday, February 26, 2015, 16:41
Shares in Wockhardt Ltd fell as much as 5.3 percent on Thursday after the drugmaker said the U.S. Food and Drug Administration had raised fresh concerns about a plant already banned from exporting to the United States over quality issues.
Last Updated: Wednesday, December 4, 2013, 09:53
Of late, the FDA has targeted the largest Indian drug manufacturing producers including Ranbaxy.
Last Updated: Wednesday, November 27, 2013, 15:46
In a filing to the BSE, the company said it has received a warning letter from USFDA for its manufacturing units located at L1, Chikalthana, Aurangabad and B15, Waluj, Aurangabad.
Last Updated: Wednesday, November 27, 2013, 11:36
A second plant operated by generic drugmaker Wockhardt Ltd was hit by the U.S. Food and Drug Administration with an "import alert", effectively a ban, clouding the company's earnings outlook and sending its shares down as much as 13.5 percent.
Last Updated: Tuesday, November 26, 2013, 18:32
Realty firm Unitech's scrip tanked 7.67 percent to settle at Rs 15.65, while drug major Wockhardt lost 4.06 percent to end the day at Rs 472.
Last Updated: Thursday, November 7, 2013, 21:52
Leading stock exchange NSE has revised circuit limits for shares of 1,439 companies, including Kingfisher Airlines, Muthoot Finance, Wockhardt, Reliance MediaWorks, as part of its surveillance action.
Last Updated: Friday, October 25, 2013, 15:01
The company had posted a consolidated net profit of Rs 453.55 crore in the same quarter last fiscal.
Last Updated: Tuesday, October 22, 2013, 14:02
UK's health regulator has imposed restrictions on import of medicines made at Wockhardt's unit at Kadaiya in Nani Daman for violation of norms, the second plant of the firm to face such action in as many weeks.
Last Updated: Saturday, October 5, 2013, 23:25
Madras High Court on Saturday directed the concerned Drugs Controller to take inventory of banned dextropropoxyphene, a pain killer, held in the warehouses of its manufacturer Wockhardt and distributors within two weeks and keep them sealed separately.
Last Updated: Tuesday, September 24, 2013, 15:43
The US health regulators, which has been cracking the whip against many Indian pharmaceutical firms, including Ranbaxy Laboratories and Wockhardt, is also recruiting and training additional drugs investigators in India.
more videos >>
